Latest news about Earkart
Earkart
125.00
0.00(0.00%)
Company Performance:
View Company Insights1D0.00%
1M-18.83%
6M-28.57%
1Y-12.13%
5Y-12.13%
More news about Earkart
30Mar 26
Earkart Limited Appoints M/s. Arvind Aggarwal & Associates as Internal Auditor for FY 2025-26
Earkart Limited has appointed M/s. Arvind Aggarwal & Associates (FRN: 039062N) as Internal Auditor for FY 2025-26, with Board approval on March 30, 2026. The Chartered Accountant firm specializes in internal audit, tax consultancy and related services. This appointment ensures regulatory compliance with SEBI Listing Regulations and strengthens the company's internal audit framework.
20Mar 26
Earkart Ltd Schedules Board Meeting on March 30, 2026 to Review IPO Proceeds Utilization
Earkart Ltd has scheduled a board meeting for March 30, 2026, to consider variation in IPO proceeds utilization and extension of time limits for fund deployment. The company notified BSE Limited on March 20, 2026, in compliance with SEBI LODR Regulation 29. The meeting agenda focuses on modifying the objects and terms of IPO proceeds utilization, representing an important corporate governance decision for the company.
11Mar 26
Earkart Limited Board Approves Land Acquisition and Pharmaceutical Business Expansion
Earkart Limited's board approved acquisition of land for manufacturing facility and pharmaceutical business during meeting on 11 March 2026. The company acknowledged the meeting was held on short notice due to urgent matters, causing delayed BSE intimation under SEBI regulations. Management assured stakeholders that compliance measures are being strengthened for future proceedings.
26Feb 26
Earkart Limited Incorporates US Subsidiary Earkart Inc. for American Market Expansion
Earkart Limited has incorporated wholly owned subsidiary Earkart Inc. in Delaware, United States, on 20th January 2026 to expand its hearing-care business in the American market. The subsidiary is authorized to issue 1,000 shares of common stock at $0.1 par value, all fully subscribed by the parent company for 100% ownership. Earkart Inc. will focus on developing remote audiology platforms, hearing tests, hearing aid distribution, and digital health solutions while partnering with healthcare providers and retailers across the United States.
14Feb 26
Earkart Limited Secures ₹4.13 Crore Government Order from ALIMCO via GeM Portal
Earkart Limited has been awarded a government order worth ₹4,12,76,400 from ALIMCO through the GeM portal for supplying BTE hearing aids. The one-time domestic supply contract is expected to contribute positively to the company's revenue, with no related party transactions or promoter group interests involved.
14Jan 26
Earkart Limited Secures ₹2.77 Crore Government Contract Through GeM Portal
Earkart Limited has been awarded a government contract worth ₹2.77 crores through the Government e-Marketplace (GeM) portal from Artificial Limbs Manufacturing Corporation of India (ALIMCO) for the supply of TLM Kits (LG95). The healthcare sector company made this disclosure on January 14, 2026, in compliance with SEBI regulations, confirming it as a one-time domestic supply contract with no related party transactions involved.
18Dec 25
Earkart Board Reviews Turtle Maarks LLP Investment
Earkart Limited's board met on December 18, 2025, to discuss a potential investment in Turtle Maarks LLP. The board authorized a comprehensive review of the investment proposal, appointing an Independent Director to conduct fresh valuation and due diligence. Findings will be presented at the next board meeting on December 23, 2025, for final decision-making. The company has informed BSE Limited of this development in compliance with SEBI regulations.
09Dec 25
Earkart Limited Reports Mixed H1 Results: Private Sector Growth Offsets Government Delays
Earkart Limited reported a 5% YoY revenue decline to ₹22.00 crores in H1 due to delayed government tenders. However, private sector growth of 25% partially offset the impact. The company secured ₹9.00 crores in new orders for H2 and aims to expand its OMNI audiometer installations from 56 to 110 clinics by March. Management expects a strong H2 performance to potentially compensate for the H1 shortfall.
20Nov 25
Earkart Limited Secures ₹6.25 Crore Government Contract for Digital Hearing Aid Components
Earkart Limited has been awarded a ₹6.25 crore contract by the Government e-Marketplace (GeM) to supply 26,000 sets of components for BTE Digital Hearing Aid kits to ALIMCO, under the Ministry of Social Justice and Empowerment. The contract, awarded on November 19, is expected to positively impact the company's revenue. Earkart disclosed this information to BSE Limited on November 20, in compliance with SEBI regulations.
15Nov 25
Earkart Limited Announces Board Decisions and Q2 FY2026 Results Post-IPO
Earkart Limited (BSE: 544549) held a board meeting on November 14, 2025, approving several important measures. The board authorized an ESOP scheme application, appointed N Kothari & Associates as Secretarial Auditor for FY 2025-26, and approved unaudited financial results for Q2 and H1 ending September 30, 2025. The company completed its IPO, issuing 3,315,000 equity shares at Rs 135 per share, increasing its paid-up capital to Rs 1,375.39 lakhs and generating a share premium of Rs 4,097.65 lakhs. Earkart has committed to transparency by ensuring timely disclosure of these developments to BSE Limited and making detailed financial results available on its website.
27Oct 25
Earkart's OMNI Platform Showcased at Global Otolaryngology Conference
Earkart Limited presented its next-generation OMNI platform, a remote diagnostic solution for ENT care, at the world's largest otolaryngology conference in Indianapolis, USA. The event, attended by over 5,000 specialists from more than 75 countries, featured live demonstrations of OMNI's real-time diagnostics and remote consultation capabilities. The platform garnered significant interest from ENT specialists, audiologists, and healthcare leaders, suggesting potential for expansion across North America, Europe, the Middle East, and emerging healthcare markets. Earkart, a hearing healthcare solutions provider, operates with a business model combining technology, accessibility, and social impact, with a revenue split of 69% government and 29% private.
Industry Peers
Poly Medicure
Laxmi Dental
Tarsons Products
Osel Devices
Vasa Denticity
Fabtech Technologies
Hemant Surgical Industries
Prevest Denpro
Aprameya Engineering
Nureca
1,344.00
(+1.71%)
234.13
(-1.18%)
205.13
(-1.16%)
493.00
(+4.52%)
440.00
(0.0%)
153.01
(+0.07%)
390.00
(+1.17%)
380.00
(-2.09%)
153.60
(-2.91%)
233.00
(-1.79%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
